Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $38.6000 (-1.03%) ($38.5000 - $38.8000) on Wed. Jan. 21, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.04% (three month average) | RSI | 54 | Latest Price | $38.6000(-1.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.4% a day on average for past five trading days. | Weekly Trend | CAPR advances 2.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) JNK(7%) PEJ(7%) VT(7%) XLF(7%) EWG(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.02% in a week (0% probabilities). VIXM(-5%) TLT(-3%) SLV(-2%) GLD(-2%) BND(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.02% (StdDev 4.04%) | Hourly BBV | 0 () | Intraday Trend | -0.5% | | | |
|
5 Day Moving Average | $38.92(-0.82%) | 10 Day Moving Average | $37.83(2.04%) | 20 Day Moving Average | $37.11(4.02%) | To recent high | -9% | To recent low | 13.5% | Market Cap | $760m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |